Maternal administration of superoxide dismutase and catalase in phenytoin teratogenicity

Free Radical Biology and Medicine

Volumn 26, Issue 3-4, 1999, Pages 266-274

  Winn, Louise M ^a   Wells, Peter G ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Antioxidants; Catalase; Free radical; Phenytoin; Protein oxidation; Reactive oxygen species; Superoxide dismutase; Teratogenicity

Indexed keywords

CATALASE; MACROGOL; PHENYTOIN; SUPEROXIDE DISMUTASE MACROGOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; CHEMICAL TERATOGENESIS; CLEFT PALATE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; FEMALE; MOUSE; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; TERATOGENICITY;

ABNORMALITIES, DRUG-INDUCED; ANALYSIS OF VARIANCE; ANIMALS; ANTICONVULSANTS; CATALASE; FEMALE; MATERNAL-FETAL EXCHANGE; MICE; PHENYTOIN; POLYETHYLENE GLYCOLS; PREGNANCY; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE;

ANIMALIA;

EID: 0032899624     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(98)00193-2     Document Type: Article

References (61)

1. Yerby M.S. Pregnancy, teratogenesis, and epilepsy. Neurol. Clin. 12:1994;749-769.
2. Janz D. The teratogenic risk of antiepileptic drugs. Epilepsia. 16:1975;159-169.
3. Winn L.M., Wells P.G. Free radical-mediated mechanisms of anti-convulsant teratogenicity. Eur. J. Neurol. 2:1995a;5-29.
4. Wells P.G., Winn L.M. Biochemical toxicology of chemical teratogenesis. Crit. Rev. Biochem. Mol. Biol. 31:1996;1-40.
5. Winn L.M., Wells P.G. Evidence for embryonic prostaglandin H synthase catalyzed bioactivation and reactive oxygen species-mediated oxidation of cellular macromolecules in phenytoin and benzo(a)pyrene teratogenesis. Free Radic. Biol. Med. 22:1997;607-621.
6. Hanson J.W., Smith D.W. The fetal hydantoin syndrome. Teratology. 33:1975;349-353.
7. Strickler S.M., Dansky L.V., Miller M.A., Seni M.H., Andermann E., Spielberg S.P. Genetic predisposition to phenytoin-induced birth defects. Lancet. 2:1985;746-749.
8. Van Dyke D., Hodge S.E., Heide F., Hill L.R. Family studies in fetal phenytoin exposure. J. Pediatr. 113:1988;301-306.
9. Scolnik D., Nulman I., Rovet J., Gladstone D., Czuchta D., Gardner H.A., Gladstone R., Ashby P., Weksberg R., Einarson T., Koren G. Neurodevelopment of children exposed in utero to phenytoin and carbamazepine monotherapy. JAMA. 271:1994;767-770.
10. Nulman I., Scolnik D., Chitayat D., Farkas L.D., Koren G. Findings in children exposed in utero to phenytoin and carbamazepine monotherapy Independent effects of epilepsy and medications . Am. J. Med. Genet. 68:1997;18-24.
11. Hanson J.W., Myrianthopoulos N.C., Harvey M.A.S., Smith D.W. Risks to the offspring of women treated with hydantoin anticonvulsants with emphasis on fetal hydantoin syndrome. J. Pediatr. 89:1976;662-668.
12. Halliwell B., Gutteridge J.M.C. Protection against oxidants in biological systems The superoxide theory of oxygen toxicity . Halliwell B., Gutteridge J.M.C. Free radicals in biology and medicine. 2nd ed. 1989;86-187 Oxford University Press, London.
13. Fantel A.G. Reactive oxygen species in developmental toxicity review and hypothesis . Teratology. 53:1996;196-217.
14. Fridovich I. The biology of oxygen radicals. Science. 201:1978;875-880.
15. Kappas H. Overview of enzyme systems involved in bioreduction of drugs and in redox cycling. Biochem. Pharmacol. 35:1986;1-6.
16. Padmanabhan R.V., Gudapaty R., Liener I.E., Schwartz B.A., Hoidal J.R. Protection against pulmonary oxygen toxicity in rats by the intratracheal administration of liposome-encapsulated superoxide dismutase or catalase. Am. Rev. Resp. Dis. 132:1985;264-267.
17. Tamura Y., Chi L.C., Driscoll E.M. Jr, Hoff P.T., Freeman B.A., Gallagher K.P., Lucchesi B.R. Superoxide dismutase conjugated to polyethylene glycol provides sustained protection against myocardial ischemia/reperfusion injury in canine heart. Circ. Res. 63:1988;944-959.
18. Liu T.H., Beckman J.S., Freeman B.A., Hogan E.L., Hsu C.Y. Polyethylene glycol-conjugated superoxide dismutase and catalase reduce ischemic brain injury. Am. J. Physiol. 256:1989;H589-H593.
19. Oda T., Nakai I., Mituo M., Yamagishi H., Oka T., Yoshikawa T. Role of oxygen radicals and synergistic effect of superoxide dismutase and catalase on ischemia-reperfusion injury of the rat pancreas. Transplant. Proc. 24:1992;797-798.
20. Markey B.A., Phan S.H., Varani J., Ryan U.S., Ward P.A. Inhibition of cytotoxicity by intracellular superoxide dismutase supplementation. Free Radic. Biol. Med. 9:1990;307-314.
21. Das D.K., Russell J.C., Jones R.M. Reduction of cold injury by superoxide dismutase and catalase. Free Radic. Res. Comm. 12/13:1991;653-662.
22. Cadet J.L., Ladenheim B., Hirata H., Rothman R.B., Ali S., Carlson E., Epstein C., Moran T.H. Superoxide radicals mediate the biochemical effects of methylenedioxymethamphetamine (MDMA) Evidence from using CuZn-superoxide dismutase transgenic mice . Synapse. 21:1995;169-176.
23. Elroy-Stein O., Bernstein Y., Groner Y. Overproduction of human Cu/Zn-superoxide dismutase in transfected cells extenuation of paraquat-mediated cytotoxicity and enhancement of lipid peroxidation . EMBO J. 5:1986;615-622.
24. Kelner M.J., Bagnell R. Alteration of endogenous glutathione peroxidase, manganese superoxide dismutase, and glutathione transferase activity in cells transfected with a copper-zinc superoxide dismutase expression vector. Explanation for variations in paraquat resistance. J. Biol. Chem. 265:1990;10872-10875.
25. Amstad P., Peskin A., Shah G., Mirault M.-E., Moret R., Zbinden I., Cerutti P. The balance between Cu,Zn-superoxide dismutase and catalase affects the sensitivity of mouse epidermal cells to oxidative stress. Biochemistry. 30:1991;9305-9313.
26. El-Hage S., Singh S.M. Temporal expression of genes with higher mRNA levels during in utero development in mice. Develop. Genet. 11:1990;149-159.
27. Winn L.M., Wells P.G. Phenytoin-Initiated DNA oxidation in murine embryo culture, and embryo protection by the antioxidative enzymes superoxide dismutase and catalase Evidence for reactive oxygen species-mediated DNA oxidation in the molecular mechanism of phenytoin teratogenicity . Mol. Pharmacol. 48:1995b;112-120.
28. Eriksson U.J., Borg L.A.H. Protection by free oxygen radical scavenging enzymes against glucose-induced embryonic malformations in vitro. Diabetologia. 34:1991;325-331.
29. Eriksson U.J., Borg L.A.H. Diabetes and embryonic malformations. Role of substrate-induced free-oxygen radical production for dysmorphogenesis in cultured rat embryos. Diabetes. 42:1993;411-419.
30. Davis W.L., Crawford L.A., Cooper O.J., Farmer G.R., Thomas D.L., Freeman B.L. Ethanol induces the generation of reactive free radicals by neural crest cells in vitro. J. Craniofac. Genet. Dev. Biol. 10:1990;277-293.
31. Kotch L.E., Chen S.-Y., Sulik K.K. Ethanol-induced teratogenesis Free radical damage as a possible mechanism . Teratology. 52:1995;128-136.
32. Hagay Z.J., Weiss Y., Zusman I., Peled-Kamar M., Reece E.A., Eriksson U.J., Groner Y. Prevention of diabetes-associated embryopathy by over expression of the free radical scavenger copper zinc superoxide dismutase in transgenic mouse embryos. Am. J. Obstet. Gynecol. 173:1995;1036-1041.
33. Beckman J.S., Minor R.L., White C.W., Repine J.E., Rosen G.M., Freeman B.A. Superoxide dismutase and catalase conjugated to polyethylene glycol increases endothelial enzyme activity and oxidant resistance. J. Biol. Chem. 263:1988;6884-6892.
34. Levine R.L., Garland D., Oliver C.N., Amici A., Climent I., Lenz A., Ahn B., Shaltiel S., Stadtman E.R. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol. 186:1990;464-478.
35. 2 in irradiated solutions. Microchem. J. 18:1973;363-374.
36. Jiang Z.-Y., Hunt J.V., Wolff S.P. Ferrous ion oxidation in the presence of xylenol orange for the detection of lipid hydroperoxide in low density lipoprotein. Anal. Chem. 202:1992;384-389.
37. Ou P., Wolff S.P. Aminoguanidine a drug proposed for prophylaxis in diabetes inhibits catalase and generates hydrogen peroxide in vitro . Biochem. Pharmacol. 465:1993;1139-1144.
38. 2 fluxes within cells. J. Pharmacol. Exp. Ther. 277:1996;945-953.
39. Bradford M.M. A rapid sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein dye. Analyt. Biochem. 72:1976;248-254.
40. Wells, P. G.; Winn, L. M. The role of biotransformation in development toxicity. In: Sipes, I. G.; McQueen, C. A.; Gandolfi, A. J., eds. Comprehensive toxicology. Vol. 10. Boekelheide, K.; Chaplin, R.E.; Hoyer, P.B.; Harris, C. eds. Reproductive and endocrine toxicology. Section 3. Development toxicology. Pergamon Elsevier Sci. Ltd.; 1997:479-497.
41. Wells, P. G.; Winn, L. M. The role of biotransformation in development toxicity. In: Sipes, I. G.; McQueen, C. A.; Gandolfi, A. J., eds. Comprehensive toxicology. Vol. 10. Boekelheide, K.; Chaplin, R.E.; Hoyer, P.B.; Harris, C. eds. Reproductive and endocrine toxicology. Section 3. Development toxicology. Pergamon Elsevier Sci. Ltd.; 1997:479-497.
42. Kim Y.S., Kim S.U. Oligodentroglial cell death induced by oxygen radicals and its protection by catalase. J. Neurosci. Res. 29:1991;100-106.
43. Noble P.G., Antel J.P., Yong V.W. Astrocytes and catalase prevent the toxicity of catecholamines to oligodendrocytes. Brain Res. 633:1994;83-90.
44. 2 in chromaffin cells. Eur. J. Pharmacol. 293:1995;55-64.
45. Horwitz D.L., Leff J.A. Catalase and hydrogen peroxide cytotoxicity in cultured cardiac myocytes. J. Mol. Cell. Cardiol. 27:1995;909-915.
46. Mann H., McCoy M.T., Subramaniam J., Van Remmen H., Cadet J.L. Over expression of superoxide dismutase and catalase in immortalized neural cells toxic effects of hydrogen peroxide . Brain Res. 770:1997;163-168.
47. Wang D.-H., Ishii K., Zhen L.-X., Taketa K. Enhanced liver injury in acatalasemic mice following exposure to carbon tetrachloride. Arch. Toxicol. 70:1996;189-194.
48. Espeel M., Briere N., De Craemer D., Jauniaux E., Roels F. Catalase-negative peroxisomes in human embryonic liver. Cell Tissue Res. 272:1993;89-92.
49. Brooksbank B.W.L., Balazs G. Superoxide dismutase, glutathione peroxidase and lipoperoxidation in Down's syndrome fetal brain. Brain Res. 318:1984;37-44.
50. Sinet P.M. Metabolism of oxygen derivatives in down's syndrome. Ann. NY Acad. Sci. 396:1982;83-94.
51. Elroy-Stein O., Groner Y. Impaired neurotransmitter uptake in PC12 cells over expressing human Cu/Zn-superoxide dismutase implications for gene dosage effects in Down's syndrome . Cell. 52:1988;259-267.
52. Epstein C.J., Avraham K.B., Lovett M., Smith S., Elroy-Stein O., Rotman G., Bry C., Groner Y. Transgenic mice with increased Cu/Zn-superoxide dismutase activity animal model of dosage effects in Down syndrome . Proc. Natl. Acad. Sci. USA. 84:1987;8044-8048.
53. Avraham K.B., Schickler M., Sapoznikov D., Yarom R., Groner Y. Down's syndrome abnormal neuromuscular junction in tongue of transgenic mice with elevated levels of human Cu/Zn-superoxide dismutase . Cell. 54:1988;823-829.
54. Peled-Komar M., Lotem J., Okon E., Sachs L., Groner Y. Thymic abnormalities and enhanced apoptosis of thymocytes and bone marrow cells in transgenic mice over expressing Cu/Zn-superoxide dismutase implications for Down syndrome . EMBO J. 14:1995;4985-4993.
55. Groner Y., Elroy-Stein O., Avraham K., Yarom R., Schickler M., Knobler H., Rotman G. Down syndrome clinical symptoms are manifested in transfected cells and transgenic mice over expressing the human Cu/Zn-superoxide dismutase gene. J. Physiol. 84:1990;53-77.
56. Amstad P., Moret R., Cerutti P. Glutathione peroxidase compensates for the hypersensitivity of Cu,Zn-superoxide dismutase overproducers to oxidant stress. J. Biol. Chem. 269:1994;1606-1609.
57. Nelson S.K., Bose S.K., McCord J.M. The toxicity of high-dose superoxide suggests that superoxide can both initiate and terminate lipid peroxidation in the reperfused heart. Free Radic. Biol. Med. 16:1994;195-200.
58. Beckman J.S., Carson M., Smith C.D., Koppenol W.H. ALS, SOD and peroxynitrite. Nature. 364:1993;584-587.
59. Peskin A.V., Koen Y.M., Zbarsky I.B. Some features of nucleo-cytoplasmic RNA transport from isolated nuclei. Mol. Biol. Rep. 7:1981;25-30.
60. White C.W., Jackson J.H., Abuchowski A., Kazo G.M., Mimmack R.F., Berger E.M., Freeman B.A., McCord J.M., Repine J.E. Polyethylene glycol-attached antioxidant enzymes decrease pulmonary oxygen toxicity in rats. J. Appl. Physiol. 66:1989;584-590.
61. Baudrimont I., Betbeder A.-M., Gharbi A., Pfohl-Leszkowicz A., Dirheimer G., Creppy E.E. Effect of superoxide dismutase and catalase on the nephrotoxicity induced by subchronical administration of ochratoxin A in rats. Toxicology. 89:1994;101-111.